Rising Pharmaceutical Companies: Array BioPharma Inc(NASDAQ:ARRY), Catalyst Pharmaceutical Partners, Inc.(NASDAQ:CPRX), and Ampio Pharamceuticals Inc(NYSEMKT:AMPE)
New York, NY – 09/16/2014 – HotStockGains provides investors and traders with valuable trading strategies via text message and email. To join our free text message alerts service just text the word BREAKOUT to 555888 from your cell phone. Just text STOP to unsubscribe if you ever need to.
Array BioPharma Inc(NASDAQ:ARRY) gained eleven cents to move to a new closing price of $3.75, a 3.02% increase in value from the previous closing price. The stock has traded within a range of $3.39 to $6.66 over the past 52 weeks. Array BioPharma Inc(NASDAQ:ARRY) had a trading volume of 1.76 million yesterday, a figure which is 0.63 million higher than its three month average volume of 1.13 million. On Sept. 11th, the company appointed Victor Sandor, M.D. to the position of Chief Medical Officer.
What Does The Future Hold For Array BioPharma? Click Here For A Free ARRY Analysis.
Catalyst Pharmaceutical Partners, Inc.(NASDAQ:CPRX) saw its value increase by 1.94% yesterday as the stock rose six cents to reach a closing price of $3.15. The company traded within a range of $3.12 to $3.36 during the day after opening at a price of $3.26. Catalyst Pharmaceutical Partners, Inc.(NASDAQ:CPRX) is now situated just fifty cents below its 52 week high of $3.65. The company has a bid price of $3.10 x 2,000 and an offer price of $3.55 x 2,000.
Can Catalyst Pharmaceuticals Surpass Its 52 Week High? View Our Free CPRX Analysis.
Ampio Pharmaceuticals Inc(NYSEMKT:AMPE) enjoyed a 1.39% increase in value yesterday as the stock gained five cents to move to a new closing price of $3.65. The stock nevertheless remains just twenty-two cents above its 52 week low of $3.43. To contrast, Ampio Pharmaceuticals Inc(NYSEMKT:AMPE) is now situated $7.23 below its 52 week high of $10.86. On Monday, the company announced that it will be providing a webcast of its annual meeting of shareholders set to occur on Sept. 20th, 2014.
Should You Plan To Buy Ampio Shares Before The Shareholder Meeting? Take A Look At Our Free AMPE Analysis.
I have a confession to make – I am not always right. Sometimes, unfortunately, I will send alerts that experience losses.
I have alerted companies that rallied 100% or even 6,000% (not even joking) in under a week. Likewise, I have alerted companies that tanked 10, 20, sometimes even as much as 30 or 40%. However overall it is about the net result that delivers profits into your portfolio.
Sign up for my free newsletter to receive market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks. If you are not satisfied, simply click unsubscribe.
Disclosure: HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.